The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells

Cell Reports

Volumn 16, Issue 6, 2016, Pages 1629-1641

  Jin, Xun ^a,b,e,f   Jeon, Hye Min ^a   Jin, Xiong ^a   Kim, Eun Jung ^a   Yin, Jinlong ^c   Jeon, Hee Young ^a   Sohn, Young Woo ^a   Oh, Se Yeong ^a   Kim, Jun Kyum ^a   Kim, Sung Hak ^a,d   Jung, Ji Eun ^a,c   Kwak, Sungwook ^a   Tang, Kai Fu ^e   Xu, Yunsheng ^e   Rich, Jeremy N ^b   Kim, Hyunggee ^a  

^a Korea University   (South Korea)

^b LERNER RESEARCH INSTITUTE   (United States)

^c National Cancer Center   (South Korea)

^d University of Alabama at Birmingham   (United States)

^e THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^f TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

CULLIN3; DVL2; GLI2; glioblastoma stem cells; ID1

Indexed keywords

BETA CATENIN; CULLIN; CULLIN 3; INHIBITOR OF DIFFERENTIATION 1; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; CUL3 PROTEIN, HUMAN; CUL3 PROTEIN, MOUSE; ID1 PROTEIN, HUMAN; IDB1 PROTEIN, MOUSE; SHH PROTEIN, HUMAN; SHH PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ARTICLE; ASTROCYTE; BINDING SITE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELL PROLIFERATION; CELL SELF-RENEWAL; DNA SEQUENCE; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEOMICS; STEM CELL; UBIQUITINATION; ANIMAL; BRAIN TUMOR; CANCER STEM CELL; METABOLISM; MOUSE; PHYSIOLOGY; TUMOR CELL LINE; WNT SIGNALING;

ANIMALS; BETA CATENIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CULLIN PROTEINS; GLIOBLASTOMA; HEDGEHOG PROTEINS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; NEOPLASTIC STEM CELLS; WNT SIGNALING PATHWAY;

EID: 84979743444     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.092     Document Type: Article

References (40)

1. Anido, J., Sáez-Borderías, A., Gonzàlez-Juncà, A., Rodón, L., Folch, G., Carmona, M.A., Prieto-Sánchez, R.M., Barba, I., Martínez-Sáez, E., Prudkin, L., et al. TGF-β receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 18 (2010), 655–668.
2. Becher, O.J., Hambardzumyan, D., Fomchenko, E.I., Momota, H., Mainwaring, L., Bleau, A.M., Katz, A.M., Edgar, M., Kenney, A.M., Cordon-Cardo, C., et al. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res. 68 (2008), 2241–2249.
3. Bleau, A.M., Hambardzumyan, D., Ozawa, T., Fomchenko, E.I., Huse, J.T., Brennan, C.W., Holland, E.C., PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4 (2009), 226–235.
4. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 (2008), 1061–1068.
5. Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., Ruiz i Altaba, A., HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17 (2007), 165–172.
6. Dell'albani, P., Rodolico, M., Pellitteri, R., Tricarichi, E., Torrisi, S.A., D'Antoni, S., Zappia, M., Albanese, V., Caltabiano, R., Platania, N., et al. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. Neuro-oncol. 16 (2014), 204–216.
7. Eichhorn, P.J., Rodón, L., Gonzàlez-Juncà, A., Dirac, A., Gili, M., Martínez-Sáez, E., Aura, C., Barba, I., Peg, V., Prat, A., et al. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat. Med. 18 (2012), 429–435.
8. Eyler, C.E., Wu, Q., Yan, K., MacSwords, J.M., Chandler-Militello, D., Misuraca, K.L., Lathia, J.D., Forrester, M.T., Lee, J., Stamler, J.S., et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 146 (2011), 53–66.
9. Guryanova, O.A., Wu, Q., Cheng, L., Lathia, J.D., Huang, Z., Yang, J., MacSwords, J., Eyler, C.E., McLendon, R.E., Heddleston, J.M., et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19 (2011), 498–511.
10. Huang, Z., Wu, Q., Guryanova, O.A., Cheng, L., Shou, W., Rich, J.N., Bao, S., Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat. Cell Biol. 13 (2011), 142–152.
11. Jeon, H.M., Jin, X., Lee, J.S., Oh, S.Y., Sohn, Y.W., Park, H.J., Joo, K.M., Park, W.Y., Nam, D.H., DePinho, R.A., et al. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev. 22 (2008), 2028–2033.
12. Jeon, H.M., Kim, S.H., Jin, X., Park, J.B., Kim, S.H., Joshi, K., Nakano, I., Kim, H., Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression. Cancer Res. 74 (2014), 4482–4492.
13. Jijiwa, M., Demir, H., Gupta, S., Leung, C., Joshi, K., Orozco, N., Huang, T., Yildiz, V.O., Shibahara, I., de Jesus, J.A., et al. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS ONE, 6, 2011, e24217.
14. Jin, X., Yin, J., Kim, S.H., Sohn, Y.W., Beck, S., Lim, Y.C., Nam, D.H., Choi, Y.J., Kim, H., EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction. Cancer Res. 71 (2011), 7125–7134.
15. Jin, X., Kim, S.H., Jeon, H.M., Beck, S., Sohn, Y.W., Yin, J., Kim, J.K., Lim, Y.C., Lee, J.H., Kim, S.H., et al. Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Brain 135 (2012), 1055–1069.
16. Joo, K.M., Kim, S.Y., Jin, X., Song, S.Y., Kong, D.S., Lee, J.I., Jeon, J.W., Kim, M.H., Kang, B.G., Jung, Y., et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest. 88 (2008), 808–815.
17. Kim, S.H., Kim, E.J., Hitomi, M., Oh, S.Y., Jin, X., Jeon, H.M., Beck, S., Jin, X., Kim, J.K., Park, C.G., et al. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Cell Death Differ. 22 (2015), 1517–1525.
18. Lathia, J.D., Mack, S.C., Mulkearns-Hubert, E.E., Valentim, C.L., Rich, J.N., Cancer stem cells in glioblastoma. Genes Dev. 29 (2015), 1203–1217.
19. Lauth, M., Bergström, A., Shimokawa, T., Toftgård, R., Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl. Acad. Sci. USA 104 (2007), 8455–8460.
20. Lyden, D., Young, A.Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., Bader, B.L., Hynes, R.O., Zhuang, Y., Manova, K., Benezra, R., Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401 (1999), 670–677.
21. Madhavan, S., Zenklusen, J.C., Kotliarov, Y., Sahni, H., Fine, H.A., Buetow, K., Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol. Cancer Res. 7 (2009), 157–167.
22. Munoz, J.L., Rodriguez-Cruz, V., Ramkissoon, S.H., Ligon, K.L., Greco, S.J., Rameshwar, P., Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level. Oncotarget 6 (2015), 1190–1201.
23. Niola, F., Zhao, X., Singh, D., Castano, A., Sullivan, R., Lauria, M., Nam, H.S., Zhuang, Y., Benezra, R., Di Bernardo, D., et al. Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat. Cell Biol. 14 (2012), 477–487.
24. Niola, F., Zhao, X., Singh, D., Sullivan, R., Castano, A., Verrico, A., Zoppoli, P., Friedmann-Morvinski, D., Sulman, E., Barrett, L., et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. J. Clin. Invest. 123 (2013), 405–417.
25. Pulvirenti, T., Van Der Heijden, M., Droms, L.A., Huse, J.T., Tabar, V., Hall, A., Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas. Cancer Res. 71 (2011), 7280–7290.
26. Qiang, L., Wu, T., Zhang, H.W., Lu, N., Hu, R., Wang, Y.J., Zhao, L., Chen, F.H., Wang, X.T., You, Q.D., Guo, Q.L., HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ. 19 (2012), 284–294.
27. Rheinbay, E., Suvà, M.L., Gillespie, S.M., Wakimoto, H., Patel, A.P., Shahid, M., Oksuz, O., Rabkin, S.D., Martuza, R.L., Rivera, M.N., et al. An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep. 3 (2013), 1567–1579.
28. Ruiz i Altaba, A., Combinatorial Gli gene function in floor plate and neuronal inductions by Sonic hedgehog. Development 125 (1998), 2203–2212.
29. Singer, J.D., Gurian-West, M., Clurman, B., Roberts, J.M., Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 13 (1999), 2375–2387.
30. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., Dirks, P.B., Identification of human brain tumour initiating cells. Nature 432 (2004), 396–401.
31. Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R.D., Engh, J., Iwama, T., Kunisada, T., Kassam, A.B., et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28 (2009), 3949–3959.
32. Takebe, N., Harris, P.J., Warren, R.Q., Ivy, S.P., Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat. Rev. Clin. Oncol. 8 (2011), 97–106.
33. Tanaka, S., Louis, D.N., Curry, W.T., Batchelor, T.T., Dietrich, J., Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?. Nat. Rev. Clin. Oncol. 10 (2013), 14–26.
34. Waaler, J., Machon, O., von Kries, J.P., Wilson, S.R., Lundenes, E., Wedlich, D., Gradl, D., Paulsen, J.E., Machonova, O., Dembinski, J.L., et al. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 71 (2011), 197–205.
35. Wen, P.Y., Kesari, S., Malignant gliomas in adults. N. Engl. J. Med. 359 (2008), 492–507.
36. Williams, S.A., Maecker, H.L., French, D.M., Liu, J., Gregg, A., Silverstein, L.B., Cao, T.C., Carano, R.A., Dixit, V.M., USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. Cell 146 (2011), 918–930.
37. Yan, K., Wu, Q., Yan, D.H., Lee, C.H., Rahim, N., Tritschler, I., DeVecchio, J., Kalady, M.F., Hjelmeland, A.B., Rich, J.N., Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev. 28 (2014), 1085–1100.
38. Yang, W., Xia, Y., Ji, H., Zheng, Y., Liang, J., Huang, W., Gao, X., Aldape, K., Lu, Z., Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 480 (2011), 118–122.
39. Yi, L., Xiao, H., Xu, M., Ye, X., Hu, J., Li, F., Li, M., Luo, C., Yu, S., Bian, X., Feng, H., Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J. Neuroimmunol. 232 (2011), 75–82.
40. Yin, J., Park, G., Kim, T.H., Hong, J.H., Kim, Y.J., Jin, X., Kang, S., Jung, J.E., Kim, J.Y., Yun, H., et al. Pigment epithelium-derived factor (PEDF) expression induced by EGFRvIII promotes self-renewal and tumor progression of glioma stem cells. PLoS Biol., 13, 2015, e1002152.